Abstract Number: Esoc2026a2259 to Bridge or Not to Bridge? Ameta-analysis of Intravenous Thrombolysis Before Thrombectomy in Large Ischemic Core Strokes
Year: 2026
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: Background and aims Endovascular thrombectomy (EVT) is the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). However, the role of preceding intravenous thrombolysis (IVT) in patients with sizable ischemic core infarcts remains unclear. This systematic review and meta-analysis aimed to compare the clinical efficacy and safety of bridging therapy (IVT followed by EVT) versus EVT alone in this specific high-risk subgroup. Methods Following PRISMA guidelines, a comprehensive literature search was conducted across PubMed, Web of Science, and Scopus to identify studies comparing bridging therapy (IVT + EVT) with EVT alone in patients with large ischemic cores. Primary efficacy outcomes included favorable functional status, defined as modified Rankin Scale (mRS) scores of 0–1 and 0–2 Results Seven cohort studies met the inclusion criteria. No significant differences were observed between the two treatment strategies in achieving mRS 0–1 (RR = 0.78; 95% CI: 0.52–1.19; p = 0.25) or mRS 0–2 (RR = 0.70; 95% CI: 0.46–1.08; p = 0.11). Similarly, rates of sICH (RR = 0.93; 95% CI: 0.67–1.28; p = 0.64), any ICH (RR = 0.90; 95% CI: 0.79–1.04; p = 0.15), successful recanalization (RR = 0.92; 95% CI: 0.83–1.03; p = 0.14), and mortality (RR = 1.08; 95% CI: 0.96–1.21; p = 0.20) were comparable between groups. Conclusions In patients with large ischemic core infarcts, administering IVT prior to EVT does not confer significant clinical or procedural advantages over EVT alone. Conflict of interest Nothing to declare Figure 1 - belongs to Results Table 2 - belongs to Results Table 3 - belongs to Results Table 4 - belongs to Results
Source: European Stroke Journal
Institutions: Alexandria University, Mansoura University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,400
OpenAlex ID: W7160448348
FWCI:
Cites:
Cited by:
Related to: